I agree with you belfi, great entry level (that's why I'm here)....

I agree with you belfi, great entry level (that's why I'm here). Mate I wouldn't listen to massive drone he has nothing positive to say because as far as I can gather from his comments he seems to be sitting on about a reverse 3 bagger. That and he thinks I'm a robot haha. Anyway what he said about the 180 days is completely wrong. That was to provide additional info which the company has confirmed they have done. Just read the announcements.

I laid it here, quote below:

"The second US FDA approval for the MRSA analysis module should create abounce in SP, probably Q1 2021. This was submitted in March 2020 and marketupdated 4 June that LBT had 180 days to provide additional info. I calculatethat date to be 1 December for that 180 days to be up so assuming its all done."

And also here, quote again below:

We know the request for clarification and additional information was released to market 4 June 2020 and they had until 1 December 2020. But we also know the additional information was completed and submitted before the AGM presentation 25 November 2020. In fact it also said "Positive meeting with FDA to clarify additional information requirements" and "expect positive outcome during Q1 2021".

So to answer your question... v soon enough in my humble opinion.

All the best holders!